Table 3.
Management of patients
| Study | Quinine | Artemisinins | Renal replacement therapy | Invasive ventilation | Inotropic support | Exchange transfusion | Length of ICU admission (Median days, IQR) |
|---|---|---|---|---|---|---|---|
| Badiaga |
100% |
0% |
Not reported |
Not reported |
Not reported |
Not reported |
4 (2-14) |
| Blumberg |
100% |
0% |
48% |
57% |
57% |
17% |
8 (5-13) |
| Bruneel 2003 [5] |
100% |
0% |
15% |
43% |
13% |
0% |
8 (4-13) 2 (1-4) |
| Bruneel 2010 [6] |
98% |
Not reported |
20% |
29% |
27% |
0% |
4 (2-7) 5 (3-8) |
| Gachot |
100% |
0% |
Not reported |
23% |
Not reported |
Not reported |
11 (No IQR available) |
| Gonzalez |
100% |
0% |
40% |
50% |
Not reported |
30% |
5 (3-12) |
| Khoo |
100% |
0% |
47% |
42% |
37% |
32% |
5 +/- 4(Mean) |
| Marks |
99% |
17% |
35% |
37% |
35% |
27% |
10 (7-9) |
| Nüesch |
15% (Pre-1987) 100% (1987-) |
0% |
9% |
26% |
22% |
22% |
6 (2-28) |
| Salord |
89% |
0% |
5% |
42% |
11% |
16% |
Not reported |
| Santos |
100% |
0% |
14% |
37% |
49% |
Not reported |
4 (2-12) 8 (3-27) |
| Schwake |
100% |
0% |
7% |
5% |
8% |
Not reported |
5 (3-6) |
| Thierfelder | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |